Fagron completed the acquisition of Magilab.

Fagron, a pharmaceutical company, completed the acquisition of Magilab, a specialized supplier of compounding raw materials for hospital pharmacies. Financial terms were not disclosed. This deal support Fagron’s strategy to diversify its presence in dynamic markets and highlight its disciplined M&A approach as a driver of sustainable growth.